-
Aulos Bioscience Presents New Phase 2 Data for AU-007 Demonstrating Continued Strong Anti-Tumor Activity in Advanced Cancers at AACR Annual Meeting
29 Apr 2025 14:24 GMT
… 1 dose escalation.
Most drug-related adverse events were … inhibitor therapy.
An additional Phase 2 cohort is evaluating AU- … , in advanced solid tumors: Phase 2 update,” (Abstract CT178) is … about the AU-007 clinical trial program, please visit ClinicalTrials …
-
Sickle Cell Disease Pipeline Insight 2025: Analysis Of 40+ Companies And 50+ Pipeline Drugs In The Sickle Cell Disease Pipeline Landscape
29 Apr 2025 09:02 GMT
… This treatment is currently in Phase II, with significant commercial collaboration … groundbreaking collaborations, recent drug trends, and ongoing clinical trials. The report also … Development Activities Mid Stage Products (Phase II) EPI01 (NDec): Novo …
-
D&D Pharmtech scores US patent for MASH drug candidate DD01
29 Apr 2025 06:36 GMT
D&D Pharmatech, a Korean developer of GLP-1-based therapeutics, announced Tuesday that it has secured a U.S. patent for DD01, its investigational treatment for metabolic-associated steatohepatitis (MASH).
DD01, a long-acting GLP-1/glucagon dual …
-
Digital Clinical Trial Success Persuades CAUTION to be Replaced by ADOPTION
28 Apr 2025 21:08 GMT
… five to 13 times for Phase II and Phase III trials, equating … in clinical trials. To ensure appropriate safety and efficacy profiles of new drugs … Consortium links decentralized/digital clinical trial approaches to notably higher proportional …
-
GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025
28 Apr 2025 20:10 GMT
… results from the ELMWOOD Phase 2 trial further reinforce … our ongoing and planned clinical trials, review and approvals by … and worldwide, of our drug and diagnostic candidates, pricing … cholangitis: The ELMWOOD phase II randomized controlled trial. …
-
Reversible male birth control injectable lasts 2 years, moves to phase 2 human trials
28 Apr 2025 18:18 GMT
… approval to move onto Phase 2 of human clinical trials for a male contraceptive … regulatory approval, it will launch Phase 2 in Australia this year, as … are becoming available. A new drug, YCT-529, from the University …
-
Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025
28 Apr 2025 17:38 GMT
… click here. Highlights of Phase 2 data presented at AUA2025: … to increase exposure to drug and simplify delivery … 2038. About the Phase 2 Study The Phase 2 study (NCT06663137) is … further development, potential for clinical trials to deliver statistically and…
-
ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials
28 Apr 2025 13:12 GMT
… to show benefit in two Phase II trials.
The combination was … ) and ASPEN-04 (NCT04675333) clinical trials as a first-line treatment … our novel EGFR-targeted antibody-drug conjugate, we continue our … after full Phase II data from a Phase II study of the drug in …
-
Medicenna Presents Compelling Results from the ABILITY-1 Clinical Trial at the 2025 AACR Annual Meeting
28 Apr 2025 13:00 GMT
… cancers planned for the Phase 2 combination expansion cohort, … enrolling in the Phase 2 monotherapy expansion cohort. … been studied in 5 clinical trials enrolling over 130 patients … additional clinical updates. Drug development and commercialization involve …
-
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
28 Apr 2025 13:00 GMT
… s Investigational New Drug (IND) application for a Phase 2 clinical trial evaluating HEPZATO™ … treatment alternatives.
“This randomized Phase 2 trial marks an important … patient enrollment, or unforeseen clinical trial results. For a detailed discussion …